UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016804
Receipt number R000019505
Scientific Title An epidemiologic study of irritable bowel syndrome; multicenter study in Japan
Date of disclosure of the study information 2015/03/15
Last modified on 2017/03/21 21:31:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An epidemiologic study of irritable bowel syndrome; multicenter study in Japan

Acronym

An epidemiologic study of IBS

Scientific Title

An epidemiologic study of irritable bowel syndrome; multicenter study in Japan

Scientific Title:Acronym

An epidemiologic study of IBS

Region

Japan


Condition

Condition

irritable bowel syndrome

Classification by specialty

Medicine in general Gastroenterology Psychosomatic Internal Medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to clarify the patient's background of IBS

Basic objectives2

Others

Basic objectives -Others

The purpose of this study is to clarify the clinical features of IBS

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The purpose of this study is to clarify the patient's background of IBS

Key secondary outcomes

To evaluate as follows;
1)Risk factor for severe IBS
2)Gender difference of IBS
3)Therapeutic course of IBS
4)Association between menstrual cramps and IBS
5)Association between pregnancy, parturition and IBS
6)Influence of proton pump inhibitor to IBS
7)Consultation rate of endoscopy in IBS patient
8)Association between obesity and IBS
9)Comparison of the clinical features of patient with IBS in clinic and flagship hospital
10)Association between subtype of IBS and QOL


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1)Outpatient suffering from irritable bowel syndrome
2)With informed consent obtained before participation

Key exclusion criteria

1)Subjects who were recognized unsuitable for this study by the investigator

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eiji Yamada

Organization

Saiseikai Yokohamashi Nanbu Hospital

Division name

Gastroenterology

Zip code


Address

3-2-10 Kounandai Kounan-ku, Yokohama City, Kanagawa, Japan

TEL

045-832-1111

Email

yamadae@nanbu.saiseikai.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Eiji Yamada

Organization

Saiseikai Yokohamashi Nanbu Hospital

Division name

Gastroenterology

Zip code


Address

3-2-10 Kounandai Kounan-ku, Yokohama City, Kanagawa, Japan

TEL

045-832-1111

Homepage URL


Email

yamadae@nanbu.saiseikai.or.jp


Sponsor or person

Institute

Saiseikai Yokohamashi Nanbu Hospital

Institute

Department

Personal name



Funding Source

Organization

Saiseikai Yokohamashi Nanbu Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 15 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/27129979

Number of participants that the trial has enrolled


Results

Lower MCS and female sex were risk factors for poor therapeutic response in patients with IBS.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 03 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete

2015 Year 11 Month 01 Day

Date analysis concluded

2016 Year 01 Month 01 Day


Other

Other related information

n/a


Management information

Registered date

2015 Year 03 Month 15 Day

Last modified on

2017 Year 03 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019505